Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PA) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Global Medical REIT (GMRE-PA) over the last 12 years, with Q3 2025 value amounting to $8.2 million.

  • Global Medical REIT's Interest Expenses rose 1297.68% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year increase of 1003.13%. This contributed to the annual value of $28.7 million for FY2024, which is 713.43% down from last year.
  • According to the latest figures from Q3 2025, Global Medical REIT's Interest Expenses is $8.2 million, which was up 1297.68% from $8.0 million recorded in Q2 2025.
  • Over the past 5 years, Global Medical REIT's Interest Expenses peaked at $8.5 million during Q2 2023, and registered a low of $4.8 million during Q1 2022.
  • Over the past 5 years, Global Medical REIT's median Interest Expenses value was $7.0 million (recorded in 2024), while the average stood at $6.7 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first skyrocketed by 7227.66% in 2023, then tumbled by 1743.03% in 2024.
  • Global Medical REIT's Interest Expenses (Quarter) stood at $4.8 million in 2021, then soared by 67.69% to $8.1 million in 2022, then decreased by 13.39% to $7.0 million in 2023, then increased by 8.39% to $7.6 million in 2024, then increased by 7.99% to $8.2 million in 2025.
  • Its Interest Expenses stands at $8.2 million for Q3 2025, versus $8.0 million for Q2 2025 and $7.2 million for Q1 2025.